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Abstract 
Background/Objectives: Individuals with high pre-treatment bacterial Prevotella-to-Bacteroides 
(P/B) ratio have been reported to lose more body weight on diets high in fiber than subjects with a low 
P/B ratio. Therefore, the aim of the present study was to examine potential differences in dietary weight 
loss responses between participants with low and high P/B.    
Subjects/Methods: Eighty overweight participants were randomized (52 completed) to a 500 kcal/d 
energy deficit diet with a macronutrient composition of 30 energy percentage (E%) fat, 52 E% 
carbohydrate and 18 E% protein either high (≈1500 mg calcium/day) or low (≤600 mg calcium/day) in 
dairy products for 24 weeks. Body weight, body fat, and dietary intake (by 7-day dietary records) were 
determined. Individuals were dichotomized according to their pre-treatment P/B ratio derived from 16S 
rRNA gene sequencing of collected fecal samples to test the potential modification of dietary effects 
using linear mixed models. 
Results: Independent of the randomized diets, individuals with high P/B lost 3.8 kg (95%CI, 1.8,5.8; 
P<0.001) more body weight and 3.8 kg (95% CI, 1.1, 6.5; P=0.005) more body fat compared to 
individuals with low P/B.  After adjustment for multiple covariates, individuals with high P/B ratio lost 
8.3 kg (95% CI, 5.8;10.9, P<0.001) more body weight when consuming above compared to below 30 g 
fiber/10MJ whereas this weight loss was 3.2 kg (95% CI, 0.8;5.5, P=0.008) among individuals with 
low P/B ratio [Mean difference: 5.1 kg (95% CI, 1.7;8.6, P=0.003)]. Partial correlation coefficients 
between fiber intake and weight change was 0.90 (P<0.001) among individuals with high P/B ratio and 
0.25 (P=0.29) among individuals with low P/B ratio. 
Conclusions: Individuals with high P/B lost more body weight and body fat compared to individuals 
with low P/B, confirming that individuals with a high P/B are more susceptible to weight loss on a diet 
rich in fiber. 
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Introduction 
 
Current interventions and policies have failed to stop the rise in the global obesity epidemic. Numerous 
randomized controlled trials have compared a myriad of diets for the treatment of obesity based on the 
assumption that one diet fits all without being able to provide strong evidence in favor of one or the 
other (1-5).  
Accumulating evidence is linking gut microbiota to obesity. Overall, individuals with obesity 
show decreased bacterial diversity (6) and gene richness (7, 8) and fecal transplantation even suggest a 
causal relationship between the microbiome and obesity (9-11). The composition of the gut microbiota 
has the potential to affect the efficacy of energy harvest (12) particularly though the fiber-utilization 
capacity (13), to influence the secretion of gastrointestinal hormones affecting appetite (14, 15), and 
potentially to affect human behaviour through the gut-brain-axis (16). Of note, the metabolic responses 
to different diets were recently shown to vary between individuals depending on the composition of 
their gut microbiota (17, 18). Therefore, the human gut microbiota has the potential to play a pivotal 
role in obesity management through personalized nutrition. 
Studies have suggested that the microbiota of individuals can be clustered into so-called 
enterotypes based on the genus composition (19) suggesting that such compositional differences may 
reflect dietary intake and determine the individual responses to different diets. The Bacteroides-driven 
enterotype is reported to be predominant in individuals with a high intake of protein and animal fat 
(Western diet), whereas the Prevotella-driven enterotype appears predominant in individuals that 
consume diets rich in carbohydrate and fiber (20-22). The intestinal microbial communities are resilient 
and difficult to change through dietary interventions (20, 21, 23, 24), unless extreme changes, such as 
complete removal of carbohydrates from the diet, are introduced (25). However, only a limited number 
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of studies have related microbial enterotypes to health markers, such as cholesterol and LDL (14, 22-
24). In a randomized clinical study we recently reported that participants with high Prevotella-to-
Bacteriodes (P/B) ratio were more susceptible to lose body fat on diets high in fiber than subjects with 
a low P/B ratio (24). Furthermore, participants with no detectable Prevotella spp. had a weight loss 
response similar to that of participants with high P/B ratio, suggesting that other bacterial genera might 
also be involved. 
The aim of the present study was to validate this recent finding (24) by re-analyzing an 
independent 24-week dietary intervention study (26) for potential differences in weight loss response 
between participants with no detectable Prevotella spp., low P/B ratio, and high P/B ratio 
independently of the allocated diets and stratified by macronutrient and fiber intake from the 7-day 
dietary records. As previously reported (26) no difference in macronutrient composition, dietary fiber, 
or 24 week weight loss response was observed between the two allocated diets (high and low diary). 
Therefore, it was hypothesized that participants stratified into the low- and high P/B ratio group would 
not respond differently to the two allocated diets. However, as both the allocated diets were relatively 
low in fat and high in protein, carbohydrate and dietary fiber, it was hypothesized that participants with 
high P/B ratio (and possibly also participants with no detectable Prevotella spp.) would lose more body 
weight and body fat compared to participants with low P/B ratio, especially when consuming a diet 
high in dietary fiber evaluated by 7-day dietary records.   
 
Materials and Methods 
As previously reported (26), potential participants were invited for an information meeting and a 
physical examination at a screening visit after signing the informed consent. Inclusion criteria were: 1) 
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Habitual calcium intake <800 mg/d, 2) No dairy food allergies, 3) No infectious or metabolic diseases, 
4) No use of dietary supplements during the study or 6 months prior to the study, 5) No use of 
cholesterol lowering medicine or other medication that would be expected to affect the study outcomes, 
6) No gastrointestinal diseases, 7) No participation in other clinical studies, and 8) Women could not be 
pregnant or lactating. A total of 96 overweight or obese (BMI 28-36 kg/m2) men and women aged 18-
60 years met the inclusion criteria of whom 80 participants were included in the study, which 52 
completed all 24 weeks. In this randomized, controlled, parallel design, participants were allocated to a 
500 kcal (2100 kJ)/d energy deficit diet with a macronutrient composition of 30 energy percentage 
(E%) fat, 52 E% carbohydrate and 18 E% protein that was either high (≈1500 mg calcium/day of which 
1200 mg calcium/day should be consumed in the form of dairy products) or low (≤600 mg 
calcium/day) in dairy products during a 24 week period. Energy requirements were determined at the 
dietary counselling visit at baseline and adjusted after 12 weeks based on body weight, gender, age 
(27), and physical activity level assessed by Baeckes questionnaire (28). Randomization was performed 
by staff not involved in screening of the participants and performed according to four strata: 1) women 
with BMI≤31 kg/m2, 2) women with BMI>31 kg/m2, 3) men with BMI≤31 kg/m2, 4) men with 
BMI>31 kg/m2. The participants attended seven individual dietary counselling visits and one group 
session scheduled at week 0, 2, 4, 8, 12, 16, 20 and 24 where body weight was also recorded to the 
nearest 0.1 kg (Lindeltronic 8000S, Lindell’s, Malmo, Sweden). At baseline and after 24 weeks, a fecal 
sample was collected at home, immediately cooled, transported to the Department as soon as possible, 
and aliquots were stored immediately at -80°C. Bacterial DNA was extracted from frozen fecal samples 
using the NucleoSpin® soil kit (Macherey-Nagel, Düren, Germany), 5 ng DNA was used to amplify 
the V3+V4 region of 16S rDNA genes, and operational taxonomic unit (OTU) picking was performed 
with 97% sequence similarity as previously described (26). The relative abundances of sequences 
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assigned to the Prevotella and Bacteroides genera were summarized. Furthermore, fasting blood 
samples were drawn at baseline, from where the concentrations of plasma glucose and serum insulin 
were analyzed as described elsewhere (26). At baseline and week 24, body composition was 
determined by DXA (Lunar Prodigy DXA, Madison, USA) during standardized conditions. Finally, 7-
day dietary records were obtained at both week 12 and 24, of which the mean value was calculated. 
From these mean values the intake of carbohydrate, protein, fat, and dietary fiber were categorized as 
being low or high based on the median split. Participants were instructed not to alter their habitual 
lifestyle throughout the study period beyond the instructions regarding the intervention and furthermore 
to refrain from physical activity, medicine and alcohol 48 hours prior to the visits. More information 
about the study can be found elsewhere (26). 
The study was conducted according to the guidelines laid down in the Declaration of Helsinki 
and all procedures involving human subjects were approved by the Danish National Committee on 
Health Research Ethics. Written informed consent was obtained from the participants after receiving 
oral and written information about study procedures. The study was registered on clinicaltrials.gov with 
the identifier: NCT01199835. 
 
Statistics 
Two pre-treatment P/B groups were identified by plotting, for each sample, the log-transformed-
relative abundance of Bacteroides spp. versus the log-transformed-relative abundance of Prevotella 
spp. as well as creating a histogram plotting frequency of the log-transformed-relative abundance of 
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Prevotella spp./Bacteroides spp. As indicated by a recent study (24), subjects with no detectable 
Prevotella bacteria constituted a third group (named 0-Prevotella). 
Baseline characteristics were summarized as mean ± standard deviation, median (interquartile 
range) or proportions (%). Differences between the three P/B groups were tested using one-way 
ANOVA (some variables transformed before analysis) with Bonferroni post-hoc test or Pearson’s chi-
squared test. 
Correlations between mean carbohydrate, fat, protein and fiber intake during the 24 weeks were 
analyzed by means of Pearson’s correlation coefficients and partial correlation coefficients (mutual 
adjustment of dietary components).  
Differences in body weight change from baseline between P/B groups on the two allocated diets 
were analyzed by means of linear mixed models using all available measurements. The linear mixed 
models included the three-way interaction between diet x time x P/B group strata as well as all nested 
two-way interactions and main effects and comprised additional fixed effects including age, gender, 
baseline BMI, baseline fasting glucose and insulin as well as random effects for subjects. Secondly, a 
similar analysis was carried out only removing the allocated diet from the interaction term and instead 
including it as a covariate (same analysis was done for body fat as outcome). Finally, a similar analysis 
was carried out but only replacing the two allocated diets with median split of self-reported dietary 
intake (fat E%, protein E%, carbohydrate E%, and fiber g/10MJ) one at a time (Model 2) while 
including the allocated diet as a covariate. Model 3 additionally include fat, protein, carbohydrate, and 
fiber as continues variables (except when included as exposure). Model 1 included no covariates. 
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Results are shown as correlations and mean weight change from baseline with 95% confidence 
interval (CI), and differences in weight change from baseline to end of study (week 24) were compared 
between allocated diets as well as median split of self-reported diets within each P/B group and 
between P/B groups (irrespective of diets) through pairwise comparisons using post hoc t-tests. All data 
were checked for normality and variance homogeneity. The level of significance was set at P<0.05 and 
statistical analyses were conducted using STATA/SE 14.1 (Houston, USA). 
 
Results 
Median (IQR) dietary distribution during the 24-weeks was 45.9 (43.6;47.7) E% carbohydrates, 31.7 
(29.3;34.7) E% fats, 20.0 (18.1;22.7) E% proteins, and 30.8 (26.1;36.0) g/10MJ dietary fibers.  
The low and high P/B groups are indicated with dotted lines in Figure 1. A third group (n=8) 
had no detectable Prevotella spp. and constitute a third group named 0-Prevotella. 
Overall, body weight, BMI, and the relative abundance of Bacteroides spp. and Prevotella spp. 
differed between the three P/B groups (P≤0.017), with the high P/B group having higher body weight, 
BMI, relative abundance of Prevotella spp. and lower relative abundance of Bacteroides spp. compared 
to the low P/B group (P<0.05) (Table 1). 
After the 24-week caloric restricted diet, no difference in 24 week body weight change was 
observed between the two allocated diets within the 0-Prevotella group [0.50 kg (95% CI, -5.84, 6.83; 
P=0.88)], low P/B group [0.03 kg (95% CI, -2.28, 2.34; P=0.98)], or high P/B group [1.79 kg (95% CI, 
-1.12, 4.70; P=0.23)] (Figure 2a).  
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Irrespective of the allocated diets, participants with a low P/B ratio lost 3.80 kg (95% CI, 1.77, 
5.84; P<0.001) and 4.47 kg (95% CI, 1.90, 7.04; P<0.001) less body weight compared to participants 
with high P/B ratio and 0-Prevotella, respectively. No difference was observed between participants 
with high P/B ratio and 0-Prevotella [0.66 kg (95% CI, -2.16, 3.49; P=0.65)] (Figure 2b; Table 2). 
Likewise, participants with a low P/B ratio lost 3.80 kg (95% CI, 1.13, 6.48; P=0.005) and 3.41 kg 
(95% CI, 0.11, 6.71; P=0.043) less body fat compared to participants with high P/B ratio and 0-
Prevotella, respectively. There was no difference in fat loss between participants with high P/B ratio 
and 0-Prevotella [0.40 kg (95% CI, -3.35, 4.14; P=0.84)] (Table 2). 
Macronutrient and fiber intake from the self-reported dietary intake during the 24 week was 
correlated as seen in Table S1. 
In the fully adjusted model, participants with low P/B ratio lost more body weight when 
consuming a diet above the median in carbohydrate (%) and dietary fiber (g/10MJ) (both P≤0.008) 
whereas the high P/B ratio lost more body weight when consuming a diet above the median in  
carbohydrate (%), dietary fiber (g/10MJ), and protein (%) (all P<0.001) (Table 3) [Mean difference: 
Fat: 4.0 kg (0.6;7.3, P=0.02); Carbohydrate: 4.3 kg (1.3;7.2, P=0.004); Protein: 6.6 kg (3.0;10.3, 
P<0.001); Dietary fiber: 5.1 (1.7;8.6, P=0.003)]. Furthermore, participants in the 0-Prevotella group 
lost more body weight when consuming a diet above the median in carbohydrate (%) and fat (%) (both 
P≤0.001). 
Among individuals with high P/B ratio, fat (%) (r=0.59), protein (%) (r=-0.58), and fiber 
(g/10MJ) (r=-0.84) were significantly correlated with 24-week weight change (P≤0.015) (Figure 3 & 
Figure S1), but only fiber intake remained significant after adjusting for multiple covariates (r=0.90, 
P<0.001) (Table S2).No significant correlations was found between dietary components and weight 
loss among subjects with low P/B or 0-Prevotella. 
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The correlation coefficient between baseline and post-intervention log(P/B-ratio) was 0.87 
(P<0.001) as illustrated in Figure S2 emphasizing that the P/B-ratio overall remained stable during 24 
weeks despite the observed weight loss. 
 
Discussion 
As hypothesized, participants with no detectable Prevotella spp. and high P/B ratio lost approximately 
4 kg more during 24 weeks compared to participants with low P/B ratio. Furthermore, this increased 
weight loss response among participants with no detectable Prevotella spp. and high P/B ratio was 
associated with individual macronutrient composition and dietary fiber intake estimated from 7-day 
dietary records. Specifically, among participants with high P/B ratio fiber intake above the median 
resulted in weight loss being more than twice as large, thereby explaining the entire weight loss 
difference between the low and high P/B groups. Finally, no differences in weight loss between the two 
allocated diets, differing in calcium, were observed for any of our three P/B groups. The present study 
serves as a validation of our recent observation showing an interaction between P/B ratio and dietary 
intake on weight and fat loss response in a dietary intervention studies (24).  
Recently, the distinction of enterotypes as discrete clusters was challenged by studies 
suggesting that enterotype distribution is continuous and that information may be masked within these 
enterotype clusters (29, 30). The three P/B groups in the present study were not as discrete as in our 
previous study (24); however, the population could be divided with only few individuals possibly being 
intermediate. Furthermore, a comparison of the pre –and post interventional P/B-ratio shows good 
correlation and classification agreement, emphasizing that these ratios are very stable as previously 
reported (23). From these results we cannot conclude if the P/B ratio is causally related to the different 
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effects of the diets or simply a marker of something else that we did not measure. However, the study 
highlights the relative abundance of Prevotella spp. as important in the classification of microbiota 
profiles. In agreement herewith, we recently observed that subjects with no detectable Prevotella spp. 
responded differently than subjects in the low P/B group following a dietary intervention (24). 
Although these findings were confirmed here, as the 0-Prevotella group lost more body weight 
compared to the low P/B group and supposedly lost more weight when consuming diets higher in 
carbohydrates and/or fat, this 0-Prevotella group only consisted of 8 participants. Therefore, these 
observations need further investigations to make solid conclusions. 
Administration of short chain fatty acids (SCFA) have been reported to result in a wide range of 
health benefits including improvements in blood lipid profiles, glucose homeostasis, body composition, 
and reduced body weight (31). However, studies tend to investigate all SCFA as a whole and neglect to 
report the specific effects associated with the individual SCFA with the most abundant being acetate, 
propionate, and butyrate (31). Members of the phylum Bacteroidetes are known to be efficient 
degraders of dietary fiber and include the genera Bacteroides and Prevotella (32). In vitro the 
Prevotella-driven and Bacteriodes-driven microbiota have been shown to produce different amounts 
and profiles of SCFA from the same carbohydrate substrates (13). Therefore, the differences in P/B 
ratio in the present study, observed to affect the weight loss responsiveness to a fiber rich diet, could 
potentially be explained by the efficacy of energy harvest primarily as SCFA (12) or that the 
production of SCFA affects appetite either directly in the brain or through different signaling pathway 
influencing the secretion of gastrointestinal hormones (15, 31). Improvements in post-prandial blood 
glucose and insulin after dietary fiber intake were recently found to be positively associated with the 
abundance of Prevotella (33). Therefore, the importance of pre-treatment fasting glucose and insulin to 
determine the optimal diet for weight management (34-36), might also be linked to gut microbiota 
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profiles, and we adjusted for fasting glucose and fasting insulin. However, independent of the 
mechanisms, the three P/B ratio groups may serve as a biomarker to predict future weight loss success 
on specific diets. 
Limitations of the study include that the study was not designed to examine for differences in 
responsiveness according to P/B ratio, and it is a matter of chance that we had enough participants in 
each group to provide statistical power for analyses. However, the post-hoc approach can also be 
looked upon as a strength as the study was double-blinded with respect to the P/B ratio of the 
participants, and the identified difference in dietary responsiveness cannot have been influenced by 
knowledge of the participants or investigators. Furthermore, when stratifying on P/B ratio, the 
randomized study design that should balance out known and unknown confounders are weakened, 
which is why we adjusted for a number of baseline characteristics, including age, gender, and BMI. 
Although some of the analyses, especially those for individuals with 0-Prevotella, are based on 
relatively small numbers and the validity therefore could be questioned, these findings are consistent 
with our previous findings (24), suggesting robustness of our findings. On the other hand, the 
individuals in the present study with no detectable Prevotella bacteria at baseline primarily belonged to 
the low P/B group after the 24-week intervention (see Figure S2). Furthermore, the present results are 
partly based on self-reported dietary data during a controlled dietary intervention study with regular 
dietetic counseling of the participants. As the individual differences in macronutrient and dietary fiber 
consumption during the trial were found to influence weight loss responsiveness among the high P/B 
group, we speculate that free-living dietary intake, when not counseled by dieticians, would have an 
even bigger effect. In the current study, as well as our recently published study (24), we observed that 
individuals characterized with a high P/B-ratio tended to have a higher baseline BMI. However, as only 
the individuals with high P/B-ratio that consumed more fibers lost more weight, regression towards the 
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mean is not likely to play a major role. Furthermore, baseline BMI was recently found to be identical 
whether dominated by Prevotella or Bacteriodes among >100 diabetic patients (37). At present time, 
the main limitation when using the P/B ratio as a pre-treatment determinant of dietary weight loss 
among individual is the slightly deviating cut-offs compared to previously reported (24). These 
differences in cut-off between studies could reflect population specific P/B ratios; however, more likely 
they reflect differences in the methodology of the bacterial profiling of Prevotella spp. and Bacteroides 
spp., where the present study applied 16S rRNA gene sequencing whereas the previous study applied 
quantitative polymerase chain reaction (qPCR) (23, 24). Therefore, future use of the P/B ratio to 
determine individual dietary weight loss response on different diets would need a specific reference 
methodology or at least take the specific methodology used into consideration. It should furthermore be 
noted that the fecal microbiota primarily reflects the microbiota of the distal part of the colon. 
Therefore, it remains unknown how the fecal P/B ratio relates to the bacterial composition in the 
proximal part of the colon as well as the small intestine. 
Finally, industrialized populations consuming a Western diet have microbiotas that are 
dominated by the family Bacteroidaceae (composed of four genera including Bacteroides) whereas 
traditional populations across Africa, Asia, and South America have microbiotas that are dominated by 
the family Prevotellaceae (composed of four genera including Prevotella) that has been found to 
fluctuate according to foods available during different seasons (38). Although we know that it is 
difficult to change the P/B ratio though dietary interventions (20, 21, 23, 24), we know that short term 
diets without carbohydrates (25) and seasonal difference (38) affect these genera and thereby provide 
evidence that we might be able to manipulate the P/B ratio. 
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In summary, we successfully validated the pre-treatment P/B ratio to be an important biomarker 
associated with dietary weight loss. Specifically, we found that participants having high P/B ratio had a 
larger 24 week weight loss compared to participants with low P/B ratio when advised to eat a healthy 
energy restricted diet (carbohydrate: 52E%, fat: 30 E% and protein: 18E%). This ≈4 kg differences in 
weight loss between high and low P/B ratio groups was explained by interaction with the actual diet 
consumed. Thus, individuals with a high P/B ratio were more susceptible to body weight loss, 
compared to individuals with a low P/B ratio, specifically on a diet rich in fiber and possibly also high 
in carbohydrates, high in protein and low in fat. 
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Figure legends  
 
Figure 1: Identifying three distinct Prevotella-to-Bacteriodes groups 
Before the intervention participants were observed to form two distinct groups based on the log-
transformed relative abundance of Bacteroides spp. and the log-transformed relative abundance of 
Prevotella spp. indicated with dotted lines and referred to as low (n=27) and high (n=17) Prevotella-to-
Bacteriodes (P/B) groups. Participants with no detectable Prevotella spp., referred to as the 0-
Prevotella group, constitute the third group (n=8) but was excluded from this figure. 
 
Figure 2: Change in body weight A) between and B) within diets when stratified into three 
groups according to Prevotella-to-Bacteroides (P/B) ratio 
Data are presented as estimated mean weight change from baseline for each combination of the A) diet-
time-P/B strata interaction or B) time-P/B strata interaction in the linear mixed models, which were 
additionally adjusted for age, gender, baseline BMI, fasting glucose, fasting insulin, (also diet 
allocation in panel B), and subjects. Differences in weight change from baseline were compared after 
24 weeks through pairwise comparisons using post hoc t-tests and presented as mean weight change 
from baseline with 95% confidence intervals. A) No difference in weight change was observed 
between the two diets (low and high dairy) within any of the three P/B groups (all P≤0.23) (see panel 
A). For clarity, confidence intervals were omitted from panel A. B) The two different diets were 
collapsed and differences in weight change between the three P/B groups were compared after 24 
weeks. § indicate significant difference between the low P/B group and each of the high P/B and 0-
Prevotella group (both P<0.001). 
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Figure 3: Scatter plots between dietary fiber and 24-week weight loss stratified by three 
Prevotella/Bacteroides groups 
Blue: Low P/B-ratio (n=26); Black: High P/B-ratio (n=17); Red: 0-prevotella (n=8). Pearson’s 
correlation coefficients are presented on the figure.   
 
Figure S1: Scatter plots between dietary composition and 24-week weight loss stratified by three 
Prevotella/Bacteroides groups.  
Blue: Low P/B-ratio (n=26); Black: High P/B-ratio (n=17); Red: 0-prevotella (n=8). Pearson’s 
correlation coefficients between energy intake and weight change were 0.01 (P=0.97), 0.32 (P=0.20), 
and 0.08 (P=0.86) among subjects with low P/B-ratio, high P/B-ratio and 0-Prevotella, respectively. 
The remaining correlation coefficients are listed in Table S2. 
 
Figure S2: Scatterplot between baseline and 24-week post-intervention log(Prevotella/Bacteriodes) 
Lines (x=-0.25; y=-0.25) separate low and high Prevotella/Bacteriodes-ratio. Subjects with no 
detectable Prevotella have the value “-4” on the figure. Pearson’s correlation coefficient (not including 
subjects with 0-Prevotella) is 0.87 (P<0.001; n=42). Two microbiota samples are missing at 26 weeks 
(total n=50). 
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Table 1: Baseline characteristics of the study participants stratified into three groups according to Prevotella-to-
Bacteroides (P/B) ratio 
 0-Prevotella1 (n=8) Low P/B group (n=27) High P/B group (n=17) P-value 
Age (year) 47.9±6.8 43.4±8.7 41.8±11.5 0.33 
Gender (%female / male) 100/0 88.9 /11.1 76.5 /23.5 0.24 
Body weight (kg) 82.6±4.6a 84.5±11.4a 95.1 ±12.0b 0.005 
Body mass index (kg/m2) 30.7±1.1ab 29.7±2.2a  31.9±2.8b 0.017 
Body fat (%) 48.7±3.9 44.9±4.1 44.4±5.02  0.069 
Fasting glucose (mmol/L) 5.42±0.46 5.55±0.37 5.70±0.55 0.33 
Fasting insulin (pmol/L) 63.4 (47.0;88.1) 38.5 (23.7;69.3)3  47.8 (28.8;54.6) 0.17 
Prevotella (relative abundance) 0 (0;0) a 0.0003 (0.0002;0.001) b 0.155 (0.052;0.278) c <0.001
Bacteroides (relative abundance) 0.097 (0.032;0.139)a 0.071 (0.036;0.111)a 0.012 (0.007;0.021)b <0.001
Prevotella-to-Bacteroides ratio - 0.004 (0.001;0.012) 11.67 (3.11;36.03)  
Abbreviation: P/B, Prevotella-to-Bacteroides. Data are presented as mean ± standard deviation, median (interquartile range) 
or proportions (%) and differences between the three P/B groups were tested using one-way ANOVA with Bonferroni post-
hoc tests (some variables transformed before analysis) or Pearson’s chi-squared test. Different alphabets within a row (a, b, c) 
indicate significant differences (P<0.05). 
10-Prevotella refers to the group of individuals with no detectable Prevotella spp. before intervention. 
2n=16 (missing data for one individual) 
3n=26 (missing data for one individual) 
 
 
 Table 2: Changes in body weight and body fat after 24 weeks when stratified into three 
groups according to Prevotella-to-Bacteroides ratio (n=51) 
 0-Prevotella (n=8) Low P/B (n=26) High P/B (n=17)
∆Body weight (kg) -10.62 (-12.86;-8.38)a -6.15 (-7.34;-4.96)b -9.96 (-11.50;-8.41)a 
∆Body fat (kg) -8.58 (-12.29;-4.87)a -5.18 (-6.71;-3.66)b -8.98 (-11.03;-6.95)1a 
Abbreviations: P/B, Prevotella-to-Bacteroides. Data are presented as estimated mean body 
weight and body fat change from baseline and 95% confidence intervals for three Prevotella-
to-Bacteroides groups after 24 weeks in the linear mixed models, which were additionally 
adjusted for age, gender, baseline BMI, fasting glucose, fasting insulin, diet allocation and 
random effects for subjects (only when analyzing body weight).  
Different alphabets within a row (a, b) indicate significant differences (P<0.05). 
1n=16 (missing data for one individual) 
 
Table 3: Change in body weight among the three Prevotella-to-Bacteriodes (P/B) groups stratified by median of self-reported dietary intake (n=51) 
  0-Prevotella (n=8) Low P/B (n=26) High P/B (n=17) 
  Lower median Higher median Lower median Higher median Lower median Higher median 
  (n=3) (n=5) (n=11) (n=15) (n=7) (n=10) 
Fat (E%)1 M1 -6.3 (-9.8;-2.8) -13.0 (-15.7;-10.3)2 -6.4 (-8.2;-4.6) -5.6 (-7.2;-4.1) -12.2 (-14.4;-9.9)  -7.5 (-9.4;-5.6)2 
 M2 -6.0 (-9.5;-2.4) -13.0 (-15.5;-10.5)2 -6.0 (-7.7;-4.3) -5.9 (-7.5;-4.4) -12.8 (-15.1;-10.6)  -8.1 (-10.0;-6.3)2 
 M3 -3.0 (-6.2;0.3) -13.8 (-16.1;-11.6)2 -4.9 (-6.5;-3.4) -6.9 (-8.3;-5.5) -11.6 (-13.7;-9.4)  -9.6 (-11.3;-7.8) 
        
  (n=4) (n=4) (n=11) (n=15) (n=12) (n=5) 
Protein (E%)1 M1 -11.1 (-14.1;-8.2) -9.9 (-12.8;-6.9) -6.5 (-8.3;-4.7) -5.6 (-7.1;-4.1) -7.6 (-9.3;-5.9) -13.6 (-16.3;-11.0)2 
 M2 -10.8 (-13.7;-8.0) -8.9 (-11.8;-6.0) -6.1 (-7.7;-4.5) -5.9 (-7.4;-4.3) -8.4 (-10.1;-6.8) -14.8 (-17.6;-12.0)2 
 M3 -10.4 (-13.1;-7.6) -9.3 (-12.1;-6.4) -6.1 (-7.8;-4.5) -5.7 (-7.2;-4.2) -8.6 (-10.3;-7.0) -14.8 (-17.5;-12.1)2 
        
  (n=6) (n=2) (n=12) (n=14) (n=8) (n=9) 
Carbohydrate (E%)1 M1 -9.2 (-11.5;-6.9) -14.4 (-18.3;-10.4)2 -5.2 (-6.8;-3.6) -6.6 (-8.1;-5.1) -5.7 (-7.7;-3.7) -12.7 (-14.5;-10.8)2 
 M2 -9.1 (-11.3;-6.9) -15.0 (-18.7;-11.3)2 -5.4 (-7.0;-3.8) -6.4 (-7.9;-5.0) -6.4 (-8.4;-4.4) -13.1 (-14.9;-11.3)2 
 M3 -8.3 (-10.3;-6.3) -14.8 (-18.1;-11.4)2 -4.2 (-5.7;-2.8) -7.7 (-9.1;-6.3)2 -6.0 (-8.0;-4.1) -13.8 (-15.4;-12.1)2 
        
  (n=2) (n=6) (n=12) (n=14) (n=8) (n=9) 
Dietary fiber (g/10MJ)1 M1 -10.8 (-14.5;-7.0) -10.4 (-12.6;-8.2) -4.4 (-5.9;-2.8) -7.3 (-8.8;-5.9)2 -4.7 (-6.6;-2.9) -13.5 (-15.3;-11.8)2 
 M2 -9.8 (-13.3;-6.2) -11.1 (-13.2;-8.9) -4.1 (-5.7;-2.5) -7.2 (-8.5;-5.9)2 -5.7 (-7.5;-3.8) -13.9 (-15.6;-12.3)2 
 M3 -10.0 (-13.7;-6.3) -11.0 (-13.2;-8.8) -4.1 (-5.8;-2.4) -7.3 (-8.7;-5.9)2 -5.6 (-7.6;-3.6) -13.9 (-15.6;-12.2)2 
Abbreviations: P/B, Prevotella-to-Bacteroides. Data are presented as estimated mean weight change from baseline and 95% confidence intervals for each 
combination of the dietary intake-time-P/B strata interaction after 24 weeks in the linear mixed models, which were adjusted for subject as random effects 
(M1). In model 2 (M2) additional adjustments for age, gender, baseline BMI, fasting glucose, fasting insulin, and diet allocation as fixed factors were 
performed. Model 3 (M3) include M2 + additional adjustments of fat E%, protein E%, carbohydrate E%, and fiber g/10MJ as continues variables (except when 
included as exposure). The displayed n is from M1 at week 24. 
1The approximate median value among the 49 participants having self-reported dietary intake was used as cut-off and was as following: Fat (31 E%), Protein 
(20 E%), Carbohydrate (46 E%), Fiber (30 g/10MJ).   
2Significant different (P<0.05) within P/B-group between lower and higher median of dietary component. 
 
